Fragile-X Syndrome Clinical Research Study

PI: Howard Needelman, MD
Project Title: Fragile-X Syndrome Clinical Research Study
Grant Agency: Roche Pharmaceuticals
Award: $127,343

A randomized, parallel group, double-blind, placebo-controlled, safety and exploratory efficacy and pharmacokinetic, study of R04917523 in pediatric patients with Fragile X syndrome.

;